Effect of Sirpα1 on the expression of nuclear factor-kappa B in hepatocellular carcinoma

Hepatobiliary and Pancreatic Diseases International

Volumn 6, Issue 3, 2007, Pages 276-283

  Qin, Jian Min ^a   Wan, Xing Wang ^b   Zeng, Jin Zhang ^b   Wu, Meng Chao ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Carcinoma; Hepatocellular; Nuclear transcription factor; Signal regulatory protein alpha1

Indexed keywords

ANTIBIOTIC G 418; CYCLIN D1; FAS ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; PROTEIN TYROSINE KINASE; REGULATOR PROTEIN; SIGNAL REGULATORY PROTEIN ALPHA1; SYNAPTOTAGMIN I; TYROSINE; UNCLASSIFIED DRUG; DIFFERENTIATION ANTIGEN; I KAPPA B; IMMUNOGLOBULIN RECEPTOR; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; SIRPA PROTEIN, HUMAN; TRANSCRIPTION FACTOR RELA;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENZYME ACTIVATION; ENZYME REGULATION; ENZYME SUBSTRATE; GENE CONTROL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIVER CELL CARCINOMA; LIVER REGENERATION; PLASMID; PROTEIN CONTENT; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN MOTIF; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; CELL CYCLE S PHASE; CHEMISTRY; LIVER TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANTIGENS, DIFFERENTIATION; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; HUMANS; I-KAPPA B PROTEINS; LIVER NEOPLASMS; NF-KAPPA B P50 SUBUNIT; RECEPTORS, IMMUNOLOGIC; S PHASE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

EID: 34250377248     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Xu HY, Yang YL, Guan XL, Song G, Jiang AM, Shi LJ. Expression of regulating apoptosis gene and apoptosiss index in primary liver cancer. World J Gastroenterol 2000;6: 721-724.
2. Liu LX, Jiang HC, Liu ZH, Zhu AL, Zhang WH, Wu LF, et al. Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues. Oncol Rep 2003;10:1771-1775.
3. Kharitonenkov A, Chen ZJ, Sures I, Wang H, Schilling J, Ullrich A. A family of protein, that inhibit signaling through tyrosine kinase receptors. Nature 1997;386:181-186.
4. Barclay AN, Brown MH. The SIRP family of receptors and immune regulation. Nat Rev Immunol 2006;6:457-464.
5. van den Beek EM, Cochrane F, Barclay AN. Signal regulatory proteins in the immune system. J Immunol 2005; 12:7788-7789.
6. Li B, Wang H, Chen Z. Expression and significance of signal-regulatory protein alpha in hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi 1998;20:345-347.
7. Li B, Wang H, Chen Z. The association between signal-regulatory protein alpha and hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi 1999;79:268-270.
8. Kapoor GS, Kapitonov D, O'Rourke DM. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling. Cancer Res 2004;64:6444-6452.
9. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000;21:485-495.
10. Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene 1998;17:3261-3269.
11. Cavin LG, Wang F, Factor VM, Kaur S, Venkatraman M, Thorgeirsson SS, et al. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas. Mol Cancer Res 2005;3:403-412.
12. Lienard H, Brubns P, Malbec O, Fridman WH, Daeron M. Signal regulatory proteins negatively regulate immmunoreceptor-dependent cell activation. J Biol Chem 1999;274:32493-32499.
13. Qin JM, Li SJ, Liu SQ, Zeng JZ, Man XB, Qiu XH, et al. Effect of Sirpα1 on liver regeneration after partial hepatectomy in rat. J Surg Res 2004;117:216-222.
14. Baldwin AS Jr. The NF-kappaB and IkappaB proteins, new discoveries and insights. Annu Rev Immunol 1996;14:649-683.
15. May MJ, Ghosh S. Ikappa B kinase: Kinsmen with different crafts. Science 1999;284:271-273.
16. Suh SJ, Chung TW, Son MJ, Kim SH, Moon TC, Son KH, et al. The naturally occurring biflavonoid, ochnaflavone, inhibits LPS-induced iNOS expression, which is mediated by ERK1/2 via NF-kappaB regulation, in RAW264.7 cells. Arch Biochem Biophys 2006;447:136-146.
17. Wang J, Tokoro T, Higa S, Kitajima I. Anti-inflammatory effect of pitavastatin on NF-kappaB activated by TNF-alpha in hepatocellular carcinoma cells. Biol Pharm Bull 2006;29: 634-639.
18. Qiao L, Zhang H, Yu J, Francisco R, Dent P, Ebert MP, et al. Constitutive activation of NF-kappaB in human hepatocellular carcinoma: evidence of a cytoprotective role. Hum Gene Ther 2006;17:280-290.
19. Factor V, Oliver AL, Panta GR, Thorgeirsson SS, Sonenshein GE, Arsura M. Role of Akt/PKB and Ikk complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factorα/c-myc transgenic mice. Hepatology 2001;34:32-41.
20. Foo SY, Nolan GP. NF-kappaB to the rescue: RELs, apoptosis and cellular transformation. Trends Genet 1999; 15:229-235.
21. 1 -to- S-phase transtion. Mol Cell Biol 1999;19:2690-2698.
22. Kaltschmidt B, Kaltschmidt C, Hehner SP, Droge W, Schmitz ML. Repression of NF-kappaB impairs Hela cell proliferation by functional interference with cell cycle checkpoint regulators. Oncogene 1999;18:3213-3225.
23. Subrata LS, Lowes KN, Olynyk JK, Yeoh GC, Quail EA, Abraham LJ. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines. Liver Int 2005;25:633-646.
24. Qin JM, Yan HX, Wan XW, Liu SQ, Zeng JZ, Cao HF, et al. Effects of signal regulatory proteinal on proliferation of hepatocellular carcinoma: a preliminary study. Hepatobiliary Pancreat Dis Int 2005;4:244-248.
25. Qin JM, Yan HX, Liu SQ, Wan XW, Zeng JZ, Cao HF, et al. Negatively regulating mechanism of Sirpalpha in hepatocellular carcinoma: an experimental study. Hepatobiliary Pancreat Dis Int 2006;2:246-251.
26. Yan HX, Wang HY, Zhang R, Chen L, Li BA, Liu SQ, et al. Negative regulation of hepatocellular carcinoma cell growth by signal regulatory protein alpha1. Hepatology 2004;40: 618-628.
27. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, et al. Ikk-1 and Ikk-2: cytokine-activated Ikappa B kinases essential for NF-kappa B activation. Science 1997;278:860-866.
28. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. Identification and characterization of an Ikappa B kinase. Cell 1997;90:373-383.
29. DiDonato J, Mercurio F, Rosette C, Wu-Li J, Suyang H, Ghosh S, et al. Mapping of the inducible Ikappa B phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol 1996;16:1295-1304.
30. Sriwijitkamol A, Christ-Roberts C, Berria R, Eagan P, Pratipanawatr T, DeFronzo RA, et al. Reduced skeletal muscle inhibitor of kappaB beta content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training. Diabetes 2006;55:760-767.